T. Rowe Price Investment Management
IRMD icon

T. Rowe Price Investment Management’s iRadimed IRMD Stock Holding History

T. Rowe Price Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.5M Buy
318,680
+61,983
+24% +$5.65M 0.02% 490
2026
Q1 		$24.7M Buy
256,697
+810
+0.3% +$81K 0.02% 442
2025
Q4 		$24.9M Buy
255,887
+205,783
+411% +$17.7M 0.02% 461
2025
Q3 		$3.57M Buy
+50,104
New +$3.34M ﹤0.01% 584

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Investment Management's IRMD Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its iRadimed (IRMD) stake by 24% in Q2 2026, buying an estimated $5.65M and bringing the position to 318,680 shares worth $30.5M. The position accounts for 0.02% of the portfolio, ranked #490.

T. Rowe Price Investment Management first reported a position in IRMD in Q3 2025 and has held it in 4 quarters since. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • T. Rowe Price Investment Management held 318,680 shares of iRadimed worth $30.5M as of Q2 2026.
  • T. Rowe Price Investment Management bought 61,983 iRadimed shares in Q2 2026, an estimated $5.65M.
  • iRadimed made up 0.02% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #490 holding.
  • T. Rowe Price Investment Management first reported a position in iRadimed in Q3 2025 and has held it in 4 quarters since.
  • 213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.